Avid Bioservices Inc (CDMO)

[RRdog]

Geo,

Gild is being credited with a "strategic" buy of Vrus that gave it undisputed control of the whole HVC market (huge) and cover on the flanks. The market buys Gild management and strategy and cash and balance sheet and marketing for future.

I believe that is a good way to look at things from a business perspective. Looked at in that way, a lead candidate for partnering and eventual acquisition might be BMY. They could then control the entire spectrum of strategic patenting from upstream to downstream in cancer immunotherapy, ie from PS intra and extra cellular patents all the way to their T cell
and Ligand patenting.

But, again, that is a story for another day. All I am focusing on right now is the current value discounted for risk of 2nd line NSCLC to PPHM .

Best Regards,
RRdog